Agfa Healthcare receives FDA clearance of new XERO Universal Viewer applications
Agfa Healthcare announced Thursday that the XERO Xtend functionalities of its Enterprise Imaging zero-footprint viewer have received FDA 510(k) clearance. These new features provide the company’s XERO Universal Viewer with 3D processing capabilities and “advanced clinical applications.”
James Jay, president of imaging IT solutions at Agfa Healthcare, said in an official statement that this latest news is part of the company’s “continued march forward.”
“We focus our continuous improvement efforts on meeting specific and real needs of healthcare providers; the features included in XERO Xtend fit that criterion,” Jay said. "XERO, and the XERO Xtend feature set, help the healthcare enterprises to provide anywhere, anytime image access complete with powerful, useful image processing functions.”
This announcement pertains to viewing on desktop devices only. The FDA clearance does not include XERO Xtend functionality on mobile devices at this time, according to the statement.
Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.